• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Catalog Number TF-23A
Device Problem Insufficient Information (3190)
Patient Problem Unspecified Infection (1930)
Event Date 02/28/2023
Event Type  Injury  
Manufacturer Narrative
An event of infection requiring additional surgery was reported.A more comprehensive assessment, including histopathological examination of the valve tissue could not be performed as the device remains implanted and was not returned for analysis.However, based on the information received, the reported event is consistent with non-structural valve dysfunction (nsvd).The possible risk factors for this event e.G.Active infection pre-disposing to endocarditis or patient medical history were not known.No implant related factors could be confirmed from the information received from the field as information related to implant procedure was not provided.Based on the information received, the cause of the reported incident could not be conclusively determined.There is no indication of a product quality issue with respect to labeling design or manufacturing of the device.
 
Event Description
User facility medwatch report mw5144960 received that states "(b)(6), 2017 had aortic valve surgery with trifecta 23 aortic valve.Two weeks later, additional surgery required, had infection and doctor.Removed sternum.Had to have tavr(transcatheter aortic valve replacement) to replace the trifecta 23 on (b)(6) 2023 due to issues with trifecta valve.This is just a glimpse of what i have been through since my 1st savr in 2017.Please feel free to contact us if you have any questions." it was reported that in 2017, a 23mm trifecta valve was successfully implanted during an aortic valve replacement.Two weeks later, an additional surgery was required due to infection, and the sternum was removed.On (b)(6) 2023, a transcatheter aortic valve implantation was conducted.The patient status was stable.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SJM TRIFECTA VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ST. JUDE MEDICAL #3014918977
edificio #44 calle 0, ave. 2
el coyol alajuela 1897- 4050
CS   1897-4050
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key17877195
MDR Text Key324997497
Report Number2135147-2023-04331
Device Sequence Number1
Product Code LWR
UDI-Device Identifier05414734052030
UDI-Public05414734052030
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100029
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Reporter Occupation Other
Type of Report Initial
Report Date 10/05/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/05/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberTF-23A
Was Device Available for Evaluation? No
Date Manufacturer Received09/12/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization;
-
-